The stock soared to its highest level in over 10 years on encouraging, early-stage clinical results.
News & Analysis: ArQule
Stocks were poised to ease lower on Friday morning.
ARQL earnings call for the period ending March 31, 2019.
The oncology-focused pharma announced first-quarter 2019 operating results.
This biotech recently shot up after an experimental treatment helped one patient beat back leukemia.
Find out how earnings helped these companies' shares rise.
ARQL earnings call for the period ending December 31, 2018.
The company reported fourth-quarter and full-year 2018 earnings and guidance for 2019.
ARQL earnings call for the period ending September 30, 2018.
The small-cap biopharma announced second-quarter 2018 earnings -- and a surprise profit.